+1-626-295-2442 (Worldwide) 400-606-8865 (China)
Sign in Register
English
United States Endocrinology Drugs Market Report 2018

United States Endocrinology Drugs Market Report 2018


  • Publish date: 2018-07-26  | 
  • Pages: 102  | 
  • Tables: 113  | 
  • Hits: 8

  • Publish date: 2018-07-26  | 
  • Pages: 102
  • Tables: 113  | 
  • Hits: 8
In this report, the United States Endocrinology Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

    The West

    Southwest

    The Middle Atlantic

    New England

    The South

    The Midwest

with sales (volume), revenue (value), market share and growth rate of Endocrinology Drugs in these regions, from 2013 to 2025 (forecast).

United States Endocrinology Drugs market competition by top manufacturers/players, with Endocrinology Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

    AbbVie

    AstraZeneca

    Eli Lilly

    Merck

    Novo Nordisk

    Sanofi

    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

    Diabetes Drugs

    Testosterone Replacement Drugs

    Human Growth Hormone Drugs

    Thyroid Hormone Disorder Drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

    Hospitals

    Commercial Laboratories

    Ambulatory Care Centres

    Other Setting

In spite of political and economic instability in the recent past, pharmaceutical and healthcare industry is booming across the globe. Cutting edge technology in medical devices, reformation in biotech & pharmaceuticals, and remarkable growth in the geriatric population are some of the important reasons behind rapidly flourishing healthcare and pharmaceutical industry.

QY Research has offered a comprehensive assessment of the markets in the pharmaceutical & healthcare industry in its recently published research report. This evaluation is done on the basis of historical data, quantitative & qualitative insights and flexible projections about the size of the market. As per the requirement of pharmaceutical and healthcare industry, various techniques are used on an experimental basis to make this report an exclusive one. These techniques are patient-level data, insights on medical technology & devices and comprehensive data on a number of procedures.

Strategies of top players in the pharmaceutical and healthcare industry

QY Research has provided thorough information from vendors along with a complete analysis of the performance of leading players across the globe operating in the pharmaceutical and healthcare industry. One of the important aspects covered in this report is an in-depth evaluation of various markets fall under the purview of the pharmaceutical and healthcare industry and its growth prospects in the years to come. This research report has also included the ideas exchanged between analysts and key players functioning in the industry. 

QY Research has also offered an easily navigable platform which will help clients in assessing their as well as their competitive vendors’ value. This unique feature provided by QY Research would not only help top players in the market in placing their strategies but will also guide them in successfully achieving their targets in the extremely competitive market.

Analysis of market taxonomy   

The markets covered under the purview of the pharmaceutical and healthcare sector are generally segmented as, by product, by application, by end user and by region. QY Research has given emphasis on providing segmental analysis in a comprehensive way for the better understanding of the overall market. To effectively gather market values, weighted average selling prices have been taken into consideration on the basis of products.

Further, to make this report detail and wide-ranging QY Research has used a top-down approach to evaluate market numbers for almost every category of products. On the other hand, to counter validate all the market estimations, bottom-up approach has been used by the experts in pharmaceutical and healthcare sector. While examining different segments of the markets in the pharmaceutical and healthcare industry, the analysts in QY Research have carried out several surveys along with detailed primary research.

Regional Analysis

This research report has presented various market segments with an in-depth analysis of key regions. Based on the regions the market is classified into the Middle East and Africa, Eastern & Western Europe, Latin America, the Asia Pacific including Japan and North America. The regional splits of the entire market along with its sub-segments are based on the use of the particular product in the respective regions or countries.

The research analysts in QY Research went the extra mile to provide detail information about the scope of industries in countries such as the United States, Brazil, China, Japan, Malaysia, India and South Korea. There is a huge demand for dietary supplements, veterinary drugs, medicines, human and veterinary vaccines, and blood products across the globe.

North America and Europe region, in particular, have witnessed a large demand for these products because of growing disposable income and thereby improving lifestyle. Due to increasing demands for the pharmaceutical and healthcare products, Gross Domestic Product of the regions and countries has increased and it has led to the market revenue which turns into an increase in the economy of the countries.

Lucid and coherent research reports are the forte of QY Research

For easy and better understanding and organization of the report, experts have classified the report based on the pharmaceutical and healthcare sector in three parts. The first part of the research report consists of an overview of the report which is generally known as the introduction section. This section contains a market viewpoint and in-depth information about the concerned product. 

The second part of the report includes market dynamics such as trends, drivers, restraints and various opportunities. Comprehensive information about pricing analysis is also a part of this section. Regional analysis is provided in the third part of the report.

One of its kind research methodology

The dedicated team of analysts have initially conducted primary research that include various demand-side users such as surgeons, chief opinion leaders, and physicians, while the participants from supply-side providers of various medical devices have offered valuable inputs on patient education, competitive dynamics and pricing, manufacturers and their significant strategies and development of medical devices.

To recognize the viability of the target category of technologies or products and its respective product offerings, segments, the lifespan of various medical devices and to target various healthcare facilities, QY Research has carried out secondary research. Thus each and every piece of information is gradually evaluated over the course of a research project that builds a solid base for secondary as well as primary research.

It is to be noted that these are just initial steps that are being followed by the research team of QY Research. Apart from this, to make this report an exclusive one analysts have done the forecasting based on internal methodology and models developed in QY Research that uses various macro-economic factors such as per capita income and healthcare expenditure.

QY Research, offers detail analysis, research, forecasts and data through the team of market analysts, consultants and industry experts in the process, ensuring the reliability of information through a multi-check audit process. QY Research provides advanced industry-specific models that are used in order to ensure accuracy and completeness of data


READ MORE
Table of Contents

United States Endocrinology Drugs Market Report 2018

1 Endocrinology Drugs Overview

    1.1 Product Overview and Scope of Endocrinology Drugs

    1.2 Classification of Endocrinology Drugs by Product Category

        1.2.1 United States Endocrinology Drugs Market Size (Sales Volume) Comparison by Type (2013-2025)

        1.2.2 United States Endocrinology Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2017

        1.2.3 Diabetes Drugs

        1.2.4 Testosterone Replacement Drugs

        1.2.5 Human Growth Hormone Drugs

        1.2.6 Thyroid Hormone Disorder Drugs

    1.3 United States Endocrinology Drugs Market by Application/End Users

        1.3.1 United States Endocrinology Drugs Market Size (Consumption) and Market Share Comparison by Application (2013-2025)

        1.3.2 Hospitals

        1.3.3 Commercial Laboratories

        1.3.4 Ambulatory Care Centres

        1.3.5 Other Setting

    1.4 United States Endocrinology Drugs Market by Region

        1.4.1 United States Endocrinology Drugs Market Size (Value) Comparison by Region (2013-2025)

        1.4.2 The West Endocrinology Drugs Status and Prospect (2013-2025)

        1.4.3 Southwest Endocrinology Drugs Status and Prospect (2013-2025)

        1.4.4 The Middle Atlantic Endocrinology Drugs Status and Prospect (2013-2025)

        1.4.5 New England Endocrinology Drugs Status and Prospect (2013-2025)

        1.4.6 The South Endocrinology Drugs Status and Prospect (2013-2025)

        1.4.7 The Midwest Endocrinology Drugs Status and Prospect (2013-2025)

    1.5 United States Market Size (Value and Volume) of Endocrinology Drugs (2013-2025)

        1.5.1 United States Endocrinology Drugs Sales and Growth Rate (2013-2025)

        1.5.2 United States Endocrinology Drugs Revenue and Growth Rate (2013-2025)

2 United States Endocrinology Drugs Market Competition by Players/Suppliers

    2.1 United States Endocrinology Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)

    2.2 United States Endocrinology Drugs Revenue and Share by Players/Suppliers (2013-2018)

    2.3 United States Endocrinology Drugs Average Price by Players/Suppliers (2013-2018)

    2.4 United States Endocrinology Drugs Market Competitive Situation and Trends

        2.4.1 United States Endocrinology Drugs Market Concentration Rate

        2.4.2 United States Endocrinology Drugs Market Share of Top 3 and Top 5 Players/Suppliers

        2.4.3 Mergers & Acquisitions, Expansion in United States Market

    2.5 United States Players/Suppliers Endocrinology Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Endocrinology Drugs Sales (Volume) and Revenue (Value) by Region (2013-2018)

    3.1 United States Endocrinology Drugs Sales and Market Share by Region (2013-2018)

    3.2 United States Endocrinology Drugs Revenue and Market Share by Region (2013-2018)

    3.3 United States Endocrinology Drugs Price by Region (2013-2018)

4 United States Endocrinology Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)

    4.1 United States Endocrinology Drugs Sales and Market Share by Type (Product Category) (2013-2018)

    4.2 United States Endocrinology Drugs Revenue and Market Share by Type (2013-2018)

    4.3 United States Endocrinology Drugs Price by Type (2013-2018)

    4.4 United States Endocrinology Drugs Sales Growth Rate by Type (2013-2018)

5 United States Endocrinology Drugs Sales (Volume) by Application (2013-2018)

    5.1 United States Endocrinology Drugs Sales and Market Share by Application (2013-2018)

    5.2 United States Endocrinology Drugs Sales Growth Rate by Application (2013-2018)

    5.3 Market Drivers and Opportunities

6 United States Endocrinology Drugs Players/Suppliers Profiles and Sales Data

    6.1 AbbVie

        6.1.1 Company Basic Information, Manufacturing Base and Competitors

        6.1.2 Endocrinology Drugs Product Category, Application and Specification

            6.1.2.1 Product A

            6.1.2.2 Product B

        6.1.3 AbbVie Endocrinology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

        6.1.4 Main Business/Business Overview

    6.2 AstraZeneca

        6.2.2 Endocrinology Drugs Product Category, Application and Specification

            6.2.2.1 Product A

            6.2.2.2 Product B

        6.2.3 AstraZeneca Endocrinology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

        6.2.4 Main Business/Business Overview

    6.3 Eli Lilly

        6.3.2 Endocrinology Drugs Product Category, Application and Specification

            6.3.2.1 Product A

            6.3.2.2 Product B

        6.3.3 Eli Lilly Endocrinology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

        6.3.4 Main Business/Business Overview

    6.4 Merck

        6.4.2 Endocrinology Drugs Product Category, Application and Specification

            6.4.2.1 Product A

            6.4.2.2 Product B

        6.4.3 Merck Endocrinology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

        6.4.4 Main Business/Business Overview

    6.5 Novo Nordisk

        6.5.2 Endocrinology Drugs Product Category, Application and Specification

            6.5.2.1 Product A

            6.5.2.2 Product B

        6.5.3 Novo Nordisk Endocrinology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

        6.5.4 Main Business/Business Overview

    6.6 Sanofi

        6.6.2 Endocrinology Drugs Product Category, Application and Specification

            6.6.2.1 Product A

            6.6.2.2 Product B

        6.6.3 Sanofi Endocrinology Drugs Sales, Revenue, Price and Gross Margin (2013-2018)

        6.6.4 Main Business/Business Overview

    ...

7 Endocrinology Drugs Manufacturing Cost Analysis

    7.1 Endocrinology Drugs Key Raw Materials Analysis

        7.1.1 Key Raw Materials

        7.1.2 Price Trend of Key Raw Materials

        7.1.3 Key Suppliers of Raw Materials

        7.1.4 Market Concentration Rate of Raw Materials

    7.2 Proportion of Manufacturing Cost Structure

        7.2.1 Raw Materials

        7.2.2 Labor Cost

        7.2.3 Manufacturing Expenses

    7.3 Manufacturing Process Analysis of Endocrinology Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

    8.1 Endocrinology Drugs Industrial Chain Analysis

    8.2 Upstream Raw Materials Sourcing

    8.3 Raw Materials Sources of Endocrinology Drugs Major Manufacturers in 2017

    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

    9.1 Marketing Channel

        9.1.1 Direct Marketing

        9.1.2 Indirect Marketing

        9.1.3 Marketing Channel Development Trend

    9.2 Market Positioning

        9.2.1 Pricing Strategy

        9.2.2 Brand Strategy

        9.2.3 Target Client

    9.3 Distributors/Traders List

10 Market Effect Factors Analysis

    10.1 Technology Progress/Risk

        10.1.1 Substitutes Threat

        10.1.2 Technology Progress in Related Industry

    10.2 Consumer Needs/Customer Preference Change

    10.3 Economic/Political Environmental Change

11 United States Endocrinology Drugs Market Size (Value and Volume) Forecast (2018-2025)

    11.1 United States Endocrinology Drugs Sales Volume, Revenue Forecast (2018-2025)

    11.2 United States Endocrinology Drugs Sales Volume Forecast by Type (2018-2025)

    11.3 United States Endocrinology Drugs Sales Volume Forecast by Application (2018-2025)

    11.4 United States Endocrinology Drugs Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix

    13.1 Methodology/Research Approach

        13.1.1 Research Programs/Design

        13.1.2 Market Size Estimation

        13.1.3 Market Breakdown and Data Triangulation

    13.2 Data Source

        13.2.1 Secondary Sources

        13.2.2 Primary Sources

    13.3 Disclaimer

List of Tables and Figures

    Figure Product Picture of Endocrinology Drugs

    Figure United States Endocrinology Drugs Market Size (K Units) by Type (2013-2025)

    Figure United States Endocrinology Drugs Sales Volume Market Share by Type (Product Category) in 2017

    Figure Diabetes Drugs Product Picture

    Figure Testosterone Replacement Drugs Product Picture

    Figure Human Growth Hormone Drugs Product Picture

    Figure Thyroid Hormone Disorder Drugs Product Picture

    Figure United States Endocrinology Drugs Market Size (K Units) by Application (2013-2025)

    Figure United States Sales Market Share of Endocrinology Drugs by Application in 2017

    Figure Hospitals Examples

    Table Key Downstream Customer in Hospitals

    Figure Commercial Laboratories Examples

    Table Key Downstream Customer in Commercial Laboratories

    Figure Ambulatory Care Centres Examples

    Table Key Downstream Customer in Ambulatory Care Centres

    Figure Other Setting Examples

    Table Key Downstream Customer in Other Setting

    Figure United States Endocrinology Drugs Market Size (Million USD) by Region (2013-2025)

    Figure The West Endocrinology Drugs Revenue (Million USD) and Growth Rate (2013-2025)

    Figure Southwest Endocrinology Drugs Revenue (Million USD) and Growth Rate (2013-2025)

    Figure The Middle Atlantic Endocrinology Drugs Revenue (Million USD) and Growth Rate (2013-2025)

    Figure New England Endocrinology Drugs Revenue (Million USD) and Growth Rate (2013-2025)

    Figure The South of US Endocrinology Drugs Revenue (Million USD) and Growth Rate (2013-2025)

    Figure The Midwest Endocrinology Drugs Revenue (Million USD) and Growth Rate (2013-2025)

    Figure United States Endocrinology Drugs Sales (K Units) and Growth Rate (2013-2025)

    Figure United States Endocrinology Drugs Revenue (Million USD) and Growth Rate (2013-2025)

    Figure United States Endocrinology Drugs Market Major Players Product Sales Volume (K Units) (2013-2018)

    Table United States Endocrinology Drugs Sales (K Units) of Key Players/Suppliers (2013-2018)

    Table United States Endocrinology Drugs Sales Share by Players/Suppliers (2013-2018)

    Figure 2017 United States Endocrinology Drugs Sales Share by Players/Suppliers

    Figure 2017 United States Endocrinology Drugs Sales Share by Players/Suppliers

    Figure United States Endocrinology Drugs Market Major Players Product Revenue (Million USD) (2013-2018)

    Table United States Endocrinology Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)

    Table United States Endocrinology Drugs Revenue Share by Players/Suppliers (2013-2018)

    Figure 2017 United States Endocrinology Drugs Revenue Share by Players/Suppliers

    Figure 2017 United States Endocrinology Drugs Revenue Share by Players/Suppliers

    Table United States Market Endocrinology Drugs Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)

    Figure United States Market Endocrinology Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2017

    Figure United States Endocrinology Drugs Market Share of Top 3 Players/Suppliers

    Figure United States Endocrinology Drugs Market Share of Top 5 Players/Suppliers

    Table United States Players/Suppliers Endocrinology Drugs Manufacturing Base Distribution and Sales Area

    Table United States Players/Suppliers Endocrinology Drugs Product Category

    Table United States Endocrinology Drugs Sales (K Units) by Region (2013-2018)

    Table United States Endocrinology Drugs Sales Share by Region (2013-2018)

    Figure United States Endocrinology Drugs Sales Share by Region (2013-2018)

    Figure United States Endocrinology Drugs Sales Market Share by Region in 2017

    Table United States Endocrinology Drugs Revenue (Million USD) and Market Share by Region (2013-2018)

    Table United States Endocrinology Drugs Revenue Share by Region (2013-2018)

    Figure United States Endocrinology Drugs Revenue Market Share by Region (2013-2018)

    Figure United States Endocrinology Drugs Revenue Market Share by Region in 2017

    Table United States Endocrinology Drugs Price (USD/Unit) by Region (2013-2018)

    Table United States Endocrinology Drugs Sales (K Units) by Type (2013-2018)

    Table United States Endocrinology Drugs Sales Share by Type (2013-2018)

    Figure United States Endocrinology Drugs Sales Share by Type (2013-2018)

    Figure United States Endocrinology Drugs Sales Market Share by Type in 2017

    Table United States Endocrinology Drugs Revenue (Million USD) and Market Share by Type (2013-2018)

    Table United States Endocrinology Drugs Revenue Share by Type (2013-2018)

    Figure Revenue Market Share of Endocrinology Drugs by Type (2013-2018)

    Figure Revenue Market Share of Endocrinology Drugs by Type in 2017

    Table United States Endocrinology Drugs Price (USD/Unit) by Types (2013-2018)

    Figure United States Endocrinology Drugs Sales Growth Rate by Type (2013-2018)

    Table United States Endocrinology Drugs Sales (K Units) by Application (2013-2018)

    Table United States Endocrinology Drugs Sales Market Share by Application (2013-2018)

    Figure United States Endocrinology Drugs Sales Market Share by Application (2013-2018)

    Figure United States Endocrinology Drugs Sales Market Share by Application in 2017

    Table United States Endocrinology Drugs Sales Growth Rate by Application (2013-2018)

    Figure United States Endocrinology Drugs Sales Growth Rate by Application (2013-2018)

    Table AbbVie Basic Information List

    Table AbbVie Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

    Figure AbbVie Endocrinology Drugs Sales Growth Rate (2013-2018)

    Figure AbbVie Endocrinology Drugs Sales Market Share in United States (2013-2018)

    Figure AbbVie Endocrinology Drugs Revenue Market Share in United States (2013-2018)

    Table AstraZeneca Basic Information List

    Table AstraZeneca Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

    Figure AstraZeneca Endocrinology Drugs Sales Growth Rate (2013-2018)

    Figure AstraZeneca Endocrinology Drugs Sales Market Share in United States (2013-2018)

    Figure AstraZeneca Endocrinology Drugs Revenue Market Share in United States (2013-2018)

    Table Eli Lilly Basic Information List

    Table Eli Lilly Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

    Figure Eli Lilly Endocrinology Drugs Sales Growth Rate (2013-2018)

    Figure Eli Lilly Endocrinology Drugs Sales Market Share in United States (2013-2018)

    Figure Eli Lilly Endocrinology Drugs Revenue Market Share in United States (2013-2018)

    Table Merck Basic Information List

    Table Merck Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

    Figure Merck Endocrinology Drugs Sales Growth Rate (2013-2018)

    Figure Merck Endocrinology Drugs Sales Market Share in United States (2013-2018)

    Figure Merck Endocrinology Drugs Revenue Market Share in United States (2013-2018)

    Table Novo Nordisk Basic Information List

    Table Novo Nordisk Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

    Figure Novo Nordisk Endocrinology Drugs Sales Growth Rate (2013-2018)

    Figure Novo Nordisk Endocrinology Drugs Sales Market Share in United States (2013-2018)

    Figure Novo Nordisk Endocrinology Drugs Revenue Market Share in United States (2013-2018)

    Table Sanofi Basic Information List

    Table Sanofi Endocrinology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)

    Figure Sanofi Endocrinology Drugs Sales Growth Rate (2013-2018)

    Figure Sanofi Endocrinology Drugs Sales Market Share in United States (2013-2018)

    Figure Sanofi Endocrinology Drugs Revenue Market Share in United States (2013-2018)

    Table Production Base and Market Concentration Rate of Raw Material

    Figure Price Trend of Key Raw Materials

    Table Key Suppliers of Raw Materials

    Figure Manufacturing Cost Structure of Endocrinology Drugs

    Figure Manufacturing Process Analysis of Endocrinology Drugs

    Figure Endocrinology Drugs Industrial Chain Analysis

    Table Raw Materials Sources of Endocrinology Drugs Major Players/Suppliers in 2017

    Table Major Buyers of Endocrinology Drugs

    Table Distributors/Traders List

    Figure United States Endocrinology Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)

    Figure United States Endocrinology Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)

    Figure United States Endocrinology Drugs Price (USD/Unit) Trend Forecast (2018-2025)

    Table United States Endocrinology Drugs Sales Volume (K Units) Forecast by Type (2018-2025)

    Figure United States Endocrinology Drugs Sales Volume (K Units) Forecast by Type (2018-2025)

    Figure United States Endocrinology Drugs Sales Volume (K Units) Forecast by Type in 2025

    Table United States Endocrinology Drugs Sales Volume (K Units) Forecast by Application (2018-2025)

    Figure United States Endocrinology Drugs Sales Volume (K Units) Forecast by Application (2018-2025)

    Figure United States Endocrinology Drugs Sales Volume (K Units) Forecast by Application in 2025

    Table United States Endocrinology Drugs Sales Volume (K Units) Forecast by Region (2018-2025)

    Table United States Endocrinology Drugs Sales Volume Share Forecast by Region (2018-2025)

    Figure United States Endocrinology Drugs Sales Volume Share Forecast by Region (2018-2025)

    Figure United States Endocrinology Drugs Sales Volume Share Forecast by Region in 2025

    Table Research Programs/Design for This Report

    Figure Bottom-up and Top-down Approaches for This Report

    Figure Data Triangulation

    Table Key Data Information from Secondary Sources

    Table Key Data Information from Primary Sources

null
We will be happy to help you find what you're looking for. Please call or email us
  • USA Office: +1-6262952442(International) ; +1-6265407211
  • Canada Office: +1-6133665094
We will be happy to help you find what you're looking for. Please call or email us
  • USA Office: +1-6262952442(International) ; +1-6265407211
  • Canada Office: +1-6133665094
CONTACT US
We will be happy to help you find what you're looking for. Please call or email us
  • USA Office: +1-6262952442(International) ; +1-6265407211
  • Canada Office: +1-6133665094
Our clients
<
4321
>
>